Skip to main content

Table 1 Correlation between mitochondrial superoxide dismutase (SOD2) expression and clinicopathological characteristics in 61 endometriosis-associated ovarian cancers

From: Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers

Characteristic

Cases, n

SOD2 expression, n

P value

High (n = 46)

Low (n = 15)

Age, years

 60<

11

10

1

0.2646

 ≤ 60

50

36

14

 

FIGO class

 Low (I, II)

51

38

13

0.9999

 High (III, IV)

10

8

2

 

Blood marker

 Positive

48

37

11

0.7175

 Negative

13

9

4

 

Histology

 Clear cell

41

33

8

0.2164

 Endometrioid

20

13

7

 

Treatment

 Complete

53

41

12

0.3934

 Incomplete

8

5

3

 
  1. Patients were stratified according to mitochondrial superoxide dismutase (SOD2) expression. SOD2 expression was not associated with age, International Federation of Gynecology and Obstetrics (FIGO) stage, blood markers, histology, or completeness of adjuvant primary treatment
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us